Bleed kit and defibrillator installed in phone box
A new defibrillator and bleed kit have been installed in a disused phone box as part of a community youth project.
The emergency kit is located in the newly renovated King George Telephone Box outside of St Paul's Church on Portland Square, Bristol.
The telephone box has been cleaned and painted by student volunteers from the City of Bristol College and the King's Trust.
Dan Broadbent, event manager at Circomedia who started the project, said: "The defibrillator has actually been used three times already and it's only been there for a month. Before this there wasn't a defibrillator anywhere near here so we thought it was a really important thing to do."
More news stories for Bristol
Watch the latest Points West
Listen to the latest news for Bristol
Mr Broadbent added: "I think everyone has to do their part in the community. We've been here for 20 years and we wanted to do our part to support people."
Muna Shafie is a lecturer at City of Bristol College and team leader at the King's Trust, working with young people who are not in education or training.
As part of the programme, the young people have to do a community project - and decided to renovate the phone box ready to house the emergency kits.
"It was really impactful to get young people engaged," Ms Shafie said.
"It was good for them to have that experience and be able to give back. They were really keen and enthusiastic."
Ibrahim Yusuf, one of the students who helped paint the phone box, said: "It was fun, the people I was working with, it's something you just enjoy doing. Giving back to the community."
All materials had been donated and the equipment, worth £5,000, was donated by the Great Western Air Ambulance and Bin the Blade.
Follow BBC Bristol on Facebook, X and Instagram. Send your story ideas to us on email or via WhatsApp on 0800 313 4630.
Bleed control kits installed to help save lives
What's inside a bleed kit and how to use them
'Lifesaving' bleed kits installed using grants
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
Portable devices 'life-changing' for patients
A cancer charity has donated equipment worth almost £10,000 to help palliative care patients enjoy "everyday family life". Easington's East End Cancer Relief Charity (EECR) has provided eight "life-changing" ambulatory syringe drivers to Castle Hill Hospital in Cottingham, East Yorkshire. The small and portable devices are used to continually administer a patient's medication over a set period, the charity said. Locally, the devices have recently been used by a woman attending her sister's wedding and by a teenager attending a music festival, a spokesperson added. The charity, which is already planning further fundraising events, raised a total of £9,600 through activities, including a bike ride, craft fairs, raffles and a country and western night. Charity trustee Andrea Robinson said: "We are immensely proud to be able to provide support in this way and it was fantastic to hear first-hand from the nursing staff the difference the syringe drivers make to patients' lives. "I would like to take this opportunity to say a special thank you to everyone who has helped at our events and have donated either money or goods to contribute to the funds raised," she added. EECR was originally set up in the late 1970s and over the years has raised more than £190,000. It became a registered charity in May 2023. Listen to highlights from Hull and East Yorkshire on BBC Sounds, watch the latest episode of Look North or tell us about a story you think we should be covering here. Children's cancer wig charity plans expansion Cancer patients 'priced out' of holidays, charity warns Double trek made cancer survivor 'feel alive' Hull University Teaching Hospitals NHS Trust
Yahoo
an hour ago
- Yahoo
Engineered E. Coli Transforms Waste Plastic Into Common Painkiller
New research has made encouraging progress in tackling not one but two of the biggest problems facing our planet right now: plastic pollution and the use of fossil fuels as part of drug manufacturing processes. Scientists from the University of Edinburgh in the UK have used Escherichia coli bacteria to convert molecules from the widely used polyethylene terephthalate (PET) plastic into the painkiller acetaminophen (also known as paracetamol). Like a lot of drugs today, acetaminophen is mostly made out of fossil fuels. Switching those ingredients for waste products – like plastic – could offer an ingenious way of addressing two major environmental problems in one. It's going to take a while to scale this up and prove it can be effective at an industrially and commercially viable level, so we shouldn't get too far ahead of ourselves, but there's a lot of potential in the new technology. "This work demonstrates that PET plastic isn't just waste or a material destined to become more plastic – it can be transformed by microorganisms into valuable new products, including those with potential for treating disease," says biotechnologist Stephen Wallace from the University of Edinburgh. The process starts by chemically degrading PET bottles. The resulting molecules are then fed to engineered E. coli, which use phosphate as a catalyst to convert the molecules into an organic compound containing nitrogen. Finally, these compounds are turned into the active ingredient of acetaminophen. Among the numerous advantages of the process are that it can be completed in 24 hours in a compact laboratory setup, and that it works at room temperature, so there's no need for excessive heating or cooling. What's more, the team has managed to get it working at an impressively efficient 92-percent yield. The reaction makes use of a well-established chemical reaction called the Lossen rearrangement, named after German chemist Wilhelm Lossen, who discovered it in 1872. Here, the reaction is made biocompatible so it can work in cells and living bacteria. Related: This was all done using PET bottles, but the plastic is also used extensively in food packaging, furniture, and manufacturing. This type of plastic is estimated to account for more than 350 million tons of waste per year, adding to the plastic pollution burden. The same approach might also work for other types of bacteria and other types of plastic, according to the researchers, so there's potential here for more environmentally friendly recycling and drug production options. It's a powerful example of how both natural and synthetic chemistry can be combined to find solutions to problems and drive innovation, and it may ultimately mean that E. coli plays a part in the production of our pain relief in the future. "Nature has evolved an exquisite yet limited set of chemical reactions that underpin the function of all living organisms," write the researchers. "By contrast, the field of synthetic organic chemistry can access reactivity not observed in nature, and integration of these abiotic reactions within living systems offers an elegant solution to the sustainable synthesis of many industrial chemicals from renewable feedstocks." The research has been published in Nature Chemistry. The Human Epoch Doesn't Officially Exist. But We Know When It Began. Flesh-Eating Fly Invasion Could Cause Devastation Across America Ocean Acidity Has Reached Critical Levels, And We're All Under Threat
Medscape
an hour ago
- Medscape
How a Painless Patient Fooled Every Monitor
A man in his 30s with congenital indifference to pain with anosmia (CIP) presented to a tertiary centre for elective biopsy and video-assisted thoracoscopic surgery (VATS). Post-operatively, the patient developed intermittent tachycardia, hypertension, and pyrexia. A case report by Thomas French, MD, research fellow in the Department of Cardiothoracic Surgery, Royal Infirmary of Edinburgh, Edinburgh, England, documented a rare case of congenital pain insensitivity. The Patient and His History The patient presented for an elective endoscopic ultrasound-guided biopsy (EBUS) of a lesion in his right middle bronchus and video-assisted thoracoscopic lung resection for two nodules in his right lung. He had undergone excision and adjuvant radical radiotherapy of a pT3 N0 M0 sarcoma on the right side of his neck 4 years earlier. Forty-six months later, a chest x-ray revealed a 9 mm nodule in the apical segment of his right lung. His past medical history was notable for CIP with anosmia and a host of related hospital presentations, including poorly healing ulcers, scoliosis, Staphylococcus discitis , and infected soft tissue injuries. On one occasion, he presented to the emergency department after feeling a painless 'popping' sensation in his left arm and was diagnosed with a biceps tendon rupture. Imaging revealed widespread skeletal degeneration. His condition had first come to his attention after scalding himself while working as a plumber. He had not noticed the injury until later. Subsequent genetic sequencing led to the diagnosis of CIP. He had not required analgesia following his previous surgeries but had experienced autonomic responses to pain, characterised by tachycardia, hypertension, and pyrexia. Findings and Diagnosis During EBUS, a lesion was observed at the bifurcation of the right middle and lower lobes. A VATS wedge resection of the right upper and lower lobes was performed, and three tissue samples — from the lesion, the upper lobe, and the lower lobe — were sent for histopathology. Intraoperatively, the patient's blood pressure, pulse, and respiratory rate remained stable, with no autonomic responses to surgical stimuli. He underwent EBUS of the lesion located at the bifurcation of his right middle and right lower lobes and VATS wedge resections of the right upper lobe and right lower lobe. Three samples were sent for histopathologic analysis: biopsied lesion, upper lobe wedge, and lower lobe wedge. The patient displayed no autonomic response to the primary incision while under general anaesthesia: his blood pressure, pulse rate, and respiratory rate remained constant throughout the entire operation, from the induction of anaesthesia onward. Post-operatively, the patient was started on an oxycodone patient-controlled analgesia (PCA) regime. He exhibited intermittent tachycardia, hypertension, and low-grade pyrexia in the immediate post-operative period, which resolved following administration of an opioid bolus. The PCA was stopped at 8 hours post-operatively, as he was feeling nauseous after each bolus without any analgesic benefit. As with the intravenous opioid, oral opioids and oral paracetamol in the immediate post-operative period successfully resolved the patient's tachycardia, blood pressure elevation, and pyrexia. His chest drain was removed one day after surgery, and he was discharged on the second post-operative day. Four days after the surgery, the patient was readmitted because of fever, cough, and some small-volume purulent discharge from his drain site. A repeat chest x-ray was unremarkable, and a wound swab was negative. He was empirically treated with 24 hours of intravenous antibiotics and given a short, 4-day oral course to complete at home. The team felt that a lower threshold for treating infection would be appropriate, given his diagnosis of CIP. He was discharged one day after readmission and made a good recovery. Histopathology of the lesion biopsy at the bifurcation of the right middle and lower lobe bronchus was consistent with metastatic synovial carcinoma. The same finding was reported for a nodule contained within the right upper lobe wedge. The histopathology of the lower lobe wedge was unremarkable. He was referred back to the sarcoma multidisciplinary team and underwent radiotherapy for the lower lobe nodule. Discussion 'CIP encompasses a wide range of overlapping and poorly understood phenotypes. Patient analgesic requirements are likely to vary significantly from patient to patient, but opioids can be useful in controlling the autonomic response to painful stimuli,' the authors wrote.
